Comparison of cardiac biomarkers on risk assessment of contrast-associated acute kidney injury in patients undergoing cardiac catheterization: A multicenter retrospective study.
Mehran score model
cardiac biomarkers
cardiac catheterization
contrast-associated acute kidney injury
risk assessment
Journal
Nephrology (Carlton, Vic.)
ISSN: 1440-1797
Titre abrégé: Nephrology (Carlton)
Pays: Australia
ID NLM: 9615568
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
revised:
23
07
2023
received:
03
04
2023
accepted:
09
08
2023
medline:
23
10
2023
pubmed:
25
8
2023
entrez:
24
8
2023
Statut:
ppublish
Résumé
Cardiac biomarkers' predictive value of contrast-associated acute kidney injury (CA-AKI) remains unclear. We analysed whether creatine kinase isoenzyme-MB (CKMB), cardiac troponin I (cTnI) and preoperative N-terminal pro-brain natriuretic peptide (NT-proBNP) are tied to CA-AKI patients undergoing cardiac catheterization. In the multi-center study, we included 3553 people underwent cardiac catheterization for analysis. CA-AKI was defined as the absolute increase of over 0.3 mg/dL or an increase of more than 50% compared with the baseline serum creatinine within 48 hours following cardiac catheterization. Logistic regression model and receiver operating characteristic (ROC) curves were used to examine the association between cardiac biomarkers and CA-AKI and the efficacy of Mehran risk score (MRS) model on CA-AKI prediction with and without cardiac biomarkers. Among 3553 people, 200 people eventually developed CA-AKI. The logistic regression model showed that log Cardiac biomarkers of CKMB, cTnI and NT-proBNP are all independently associated with CA-AKI among patients undergoing cardiac catheterization while NT-proBNP remains the best indicator. Adding CKMB, cTnI and NT-proBNP to MRS improved the prognostic efficacy and may be considered effective tools to predict the risk of CA-AKI in clinical practice.
Substances chimiques
Natriuretic Peptide, Brain
114471-18-0
Peptide Fragments
0
Biomarkers
0
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
588-596Subventions
Organisme : Guangdong Provincial Science and Technology Project
ID : 2020B1111170011
Organisme : Guangdong Provincial Science and Technology Project
ID : KJ022021049
Organisme : The National Science Foundation for Young Scientist of China
ID : 82070360
Informations de copyright
© 2023 Asian Pacific Society of Nephrology.
Références
Gameiro J, Lopes JA. Complete blood count in acute kidney injury prediction: a narrative review. Ann Intensive Care. 2019;9:87.
Gameiro J, Fonseca JA, Outerelo C, Lopes JA. Acute kidney injury: from diagnosis to prevention and treatment strategies. J Clin Med. 2020;9:9.
Weisbord SD, Palevsky PM, Kaufman JS, et al. Contrast-associated acute kidney injury and serious adverse outcomes following angiography. J Am Coll Cardiol. 2020;75:1311-1320.
Lei L, Xue Y, Guo Z, et al. Nomogram for contrast-induced acute kidney injury in patients with chronic kidney disease undergoing coronary angiography in China: a cohort study. BMJ Open. 2020;10:e037256.
Kusirisin P, Chattipakorn SC, Chattipakorn N. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J Transl Med. 2020;18:400.
Pflueger A, Abramowitz D, Calvin AD. Role of oxidative stress in contrast-induced acute kidney injury in diabetes mellitus. Med Sci Monit. 2009;15:RA125-RA136.
Hild J, Ritter O, Patschan S, Patschan D. Quality of care in patients undergoing coronary angiography with a known risk of contrast-associated acute kidney injury: a retrospective observational study. J Int Med Res. 2022;50:3000605221135857.
Guo Y, Xu X, Xue Y, Zhao C, Zhang X, Cai H. Mehran 2 contrast-associated acute kidney injury risk score: is it applicable to the Asian percutaneous coronary intervention population? Clin Appl Thromb Hemost. 2022;28:10760296221116353.
Xie YT, Dang Y, Zhang FF, Zhang QH, Wu HB, Liu G. Combination of serum TIMP-3, CA125, and NT-proBNP in predicting ventricular remodeling in patients with heart failure following acute myocardial infarction. Cardiovasc Diagn Ther. 2020;10:1184-1191.
Bansal N, Hyre Anderson A, Yang W, et al. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the chronic renal insufficiency cohort (CRIC) study. J Amer Soc Nephrol. 2015;26:946-956.
Bucholz EM, Whitlock RP, Zappitelli M, et al. Cardiac biomarkers and acute kidney injury after cardiac surgery. Pediatrics. 2015;135:e945-e956.
Brennan KG, Parravicini E, Lorenz JM, Bateman DA. Patterns of urinary neutrophil gelatinase-associated lipocalin and acute kidney injury in neonates receiving cardiopulmonary bypass. Children (Basel, Switzerland). 2020;7:132.
Greenberg JH, Parsons M, Zappitelli M, et al. Cardiac biomarkers for risk stratification of acute kidney injury after pediatric cardiac surgery. Ann Thorac Surg. 2021;111:191-198.
Haines R, Crichton S, Wilson J, Treacher D, Ostermann M. Cardiac biomarkers are associated with maximum stage of acute kidney injury in critically ill patients: a prospective analysis. Crit Care. 2017;21:88.
Schanz M, Schöffski O, Kimmel M, et al. Under-recognition of acute kidney injury after cardiac surgery in the ICU impedes early detection and prevention. Kidney Blood Press Res. 2022;47:50-60.
Lin KY, Chen HC, Jiang H, et al. Predictive value of admission D-dimer for contrast-induced acute kidney injury and poor outcomes after primary percutaneous coronary intervention. BMC Nephrol. 2020;21:90.
Saeidi B, Koralkar R, Griffin RL, Halloran B, Ambalavanan N, Askenazi DJ. Impact of gestational age, sex, and postnatal age on urine biomarkers in premature neonates. Pediatr Nephrol (Berlin, Germany). 2015;30:2037-2044.
Jiang QQ, Han MF, Ma K, et al. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis. World J Gastroenterol. 2018;24:2300-2310.
Koratala A, Kazory A. Natriuretic peptides as biomarkers for congestive states: the cardiorenal divergence. Dis Markers. 2017;2017:1454986.
Mine K, Ohashi A, Tsuji S, Nakashima J, Hirabayashi M, Kaneko K. B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants. Acta Paediatr. 2013;102:e347-e352.
Li G, Daniels CE, Kojicic M, et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion. 2009;49:13-20.
Di Marca S, Rando A, Cataudella E, et al. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure. Nutrit Metabol Cardiovasc Dis. 2018;28:636-642.
Kim SJ, Shin ES, Lee SG. N-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusions. Korean J Intern Med. 2008;23:78-86.
Farnsworth CW, Bailey AL, Jaffe AS, Scott MG. Diagnostic concordance between NT-proBNP and BNP for suspected heart failure. Clin Biochem. 2018;59:50-55.
Li X, Chen C, Gan F, Wang Y, Ding L, Hua W. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study. BMC Cardiovasc Disord. 2014;14:67.
Sir JJ, Cho YS, Chung WY, et al. Additive value of B-type natriuretic peptide on rest Tl-dipyridamole stress Tc-Sestamibi gated myocardial SPECT in patients with normal left ventricular systolic function. Cardiol Res Pract. 2010;2010:1-8.
Thygesen K, Mair J, Mueller C, et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the study group on biomarkers in cardiology of the ESC working group on acute cardiac care. Eur Heart J. 2012;33:2001-2006.
Wang F, Pan W, Pan S, Wang S, Ge Q, Ge J. Usefulness of N-terminal pro-brain natriuretic peptide and C-reactive protein to predict ICU mortality in unselected medical ICU patients: a prospective, observational study. Crit Care. 2011;15:R42.
Wang Z, Chen Q, Guo H, et al. Effects of dexmedetomidine on H-FABP, CK-MB, cTnI levels, neurological function and near-term prognosis in patients undergoing heart valve replacement. Exp Ther Med. 2017;14:5851-5856.
Agarwal SK, Avery CL, Ballantyne CM, et al. Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. Clin Chem. 2011;57:891-897.
Guo H, Li J, Liu H, He J. Learning dynamic treatment strategies for coronary heart diseases by artificial intelligence: real-world data-driven study. BMC Med Inform Decis Mak. 2022;22:39.
Komarova N, Panova O, Titov A, Kuznetsov A. Aptamers targeting cardiac biomarkers as an analytical tool for the diagnostics of cardiovascular diseases: a review. Biomedicine. 2022;10:10.